Literature DB >> 1591722

Frequent loss of heterozygosity at the DCC locus in gastric cancer.

S Uchino1, H Tsuda, M Noguchi, J Yokota, M Terada, T Saito, M Kobayashi, T Sugimura, S Hirohashi.   

Abstract

We examined 28 cases of surgically resected gastric cancer, excluding the diffuse type, for loss of heterozygosity (LOH) on 12 chromosomal arms using polymorphic DNA markers. LOH on chromosome 18q was detected in 61% (14 of 23) of the cases by the probes OLVIIA8, OLVIIE10, p15-65, SAM 1.1, and OS-4, and a putative common region showing LOH included the locus of the DCC tumor suppressor gene. LOH on chromosome 17p was also frequently found (8 of 19 or 42% of the cases) by the probes p10-3 and pHF12-1, and in 5 of these 6 cases the LOH on chromosome 17p was accompanied by LOH on chromosome 18q. On the other hand, the incidence of LOH was 30% or less using probes pHRnES, pHF12-65, p-c-mybE2.6, NJ3 3.2, pHF12-8, pHINS6.0, p9D11, hp2-alpha, pCMM6, and P1A5 on chromosomes 1q, 5, 6q, 7q, 9, 11p, 13q, 16q, 20, and 22q, respectively. LOH on chromosome 18q was frequent irrespective of the depth of tumor invasion, whereas the incidence of LOH on chromosome 17p was higher in the cases in which the tumor invaded beyond the muscularis propria than in those in which tumor invasion was limited to the submucosa and muscularis propria. These results suggest that LOH on chromosome 18q occurs at an earlier stage than LOH on chromosome 17p and that the inactivation of tumor suppressor genes located on chromosome 17p and 18q (e.g., the p53 and DCC genes) is critically involved in the development of the majority of gastric cancers. While alteration of the p53 gene is observed in various human cancers, that of the DCC gene is considered to occur more selectively in gastrointestinal cancers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591722

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  59 in total

1.  Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas.

Authors:  M Saegusa; Y Takano; Y Kamata; J Okayasu
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?

Authors:  Hee Jin Kim; Nayoung Kim; Yoon Jin Choi; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Hye Seung Lee; Sang-Hoon Ahn; Do Joong Park; Hyung Ho Kim; Il Tae Son; Sung-Bum Kang; Dong Ho Lee
Journal:  Gastric Cancer       Date:  2015-10-07       Impact factor: 7.370

3.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

4.  FAK and Src kinases are required for netrin-induced tyrosine phosphorylation of UNC5.

Authors:  Weiquan Li; Jennifer Aurandt; Claudia Jürgensen; Claudia Jürgense; Yi Rao; Kun-Liang Guan
Journal:  J Cell Sci       Date:  2006-01-01       Impact factor: 5.285

Review 5.  Cancer and forensic microsatellites.

Authors:  Karen Page; Eleanor A M Graham
Journal:  Forensic Sci Med Pathol       Date:  2008-02-02       Impact factor: 2.007

6.  Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer.

Authors:  D C Fang; J R Jass; D X Wang
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

7.  Decreased expression of the DCC gene in human breast carcinoma.

Authors:  K Wakita; N Kohno; Y Sakoda; Y Ishikawa; M Sakaue
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 8.  Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.

Authors:  J A Ajani; P F Mansfield; D M Ota
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

9.  Gastric dysplasia may be an independent risk factor of an advanced colorectal neoplasm.

Authors:  Rack Cheon Bae; Seong Woo Jeon; Han Jin Cho; Min Kyu Jung; Young Oh Kweon; Sung Kook Kim
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

10.  Decreased expression of DCC mRNA in gastric and colorectal cancer.

Authors:  M Kataoka; T Okabayashi; K Orita
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.